The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
about
The cholinergic hypothesis of Alzheimer's disease: a review of progressEffects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in ratsThe mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prismsDual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.Mechanism of tacrine block at adult human muscle nicotinic acetylcholine receptors.Potential neurotoxicity of a novel aminoacridine analogue.Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.Measurements of tacrine and monoamines in brain by in vivo microdialysis argue against release of monoamines by tacrine at therapeutic dosesEffect of distigmine bromide on the central cholinergic system.Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.Action of tacrine on muscarinic receptors in rat intestinal smooth muscle.Purification of acetylcholinesterase by 9-amino-1,2,3,4-tetrahydroacridine from human erythrocytes.Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat.
P2860
Q22242019-AD509EDA-9ED7-4282-A2DB-43B2963AF8A4Q28324606-BC14807F-4402-4110-AACA-1F336591E543Q28354362-686F0D8A-5E33-4C0E-BF6C-2F44BB646497Q39868204-6494FC11-EFCD-478D-8272-AEB29D09EF4AQ40708436-3C3D7AFB-3AA3-4A98-B8CE-6B20A05495A7Q41337098-409BA5EA-40EE-4708-9881-47B764756C44Q41768272-8766D326-FA16-4C8C-B98F-CE5371634C38Q42713800-76DFA1D8-EB44-45A1-AA55-EAD6538A7A9AQ43690891-2019A08F-3DFF-489D-B73F-CA861DE147FEQ43713315-564F87D8-09A0-4C53-966F-07C7E11E7D9BQ43778493-F2239DAD-E47D-4F9D-BF3A-F648096B0CA5Q44635772-51D57C2A-DFD4-4329-BEB9-3A9584E35E4EQ46513880-B519CE8A-D4D1-4AB4-9FDB-6C30E58CF5CCQ52584459-040C7DC0-3886-4900-BF15-EB89E8CB5C21
P2860
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
@en
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
@nl
type
label
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
@en
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
@nl
prefLabel
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
@en
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
@nl
P2093
P2860
P1476
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
@en
P2093
P2860
P356
10.1111/J.1476-5381.1989.TB16865.X
P407
P577
1989-09-01T00:00:00Z